Patent details

EP1442023 Title: CRYSTALLINE SODIUM SALT OF TELMISARTAN AND THE USE OF THE SAME AS AN ANGIOTENSIN ANTAGONIST

Basic Information

Publication number:
EP1442023
PCT Application Number:
PCT/EP/2002/011394
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027773050
PCT Publication Number:
WO/2003/037876
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
CRYSTALLINE SODIUM SALT OF TELMISARTAN AND THE USE OF THE SAME AS AN ANGIOTENSIN ANTAGONIST
French Title of Invention:
SEL DE SODIUM CRISTALLISE DE TELMISARTAN ET SON UTILISATION COMME ANTAGONISTE DE L'ANGIOTENSINE
German Title of Invention:
KRISTALLINES NATRIUMSALZ DES TELMISARTANS UND DESSEN VERWENDUNG ALS ANGIOTENSIN ANTAGONIST
SPC Number:

Dates

Filing date:
11/10/2002
Grant date:
15/08/2007
EP Publication Date:
15/08/2007
PCT Publication Date:
08/05/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2004
EP B1 Publication Date:
15/08/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/10/2015
Expiration date:
11/10/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/10/2002
 
 

Name:
Boehringer Ingelheim Pharma GmbH & Co.KG
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
HOF Irmgard
Address:
Germany (DE)

2

Name:
DONSBACH Kai
Address:
Germany (DE)

Priority

Priority Number:
10153737
Priority Date:
31/10/2001
Priority Country:
Germany (DE)

Classification

Main IPC Class:
C07D 235/20;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages